On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...
The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...
In the final days of the Biden administration, the U.S. Department of Health and Human Services’ Centers for Medicare and ...
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Biden adds Ozempic to list for Medicare price negotiationIn one of its last actions, the Biden ...
In August of 2024, the U.S. Department of Health and Human Services began negotiating drug prices for 10 different types of ...
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
Medicare adds 15 drugs, including Ozempic and Wegovy, to its price negotiation list, aiming to save billions. Incoming Trump ...
Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.